Prazitel 230/20 mg Flavoured Film-Coated Tablets for Cats
Prazitel 230/20 mg Flavoured Film-Coated Tablets for Cats
Authorised
- Praziquantel
- Pyrantel embonate
Product identification
Medicine name:
Prazitel 230/20 mg Flavoured Film-Coated Tablets for Cats
Prazitel 230/20 mg aromatizētas apvalkotās tabletes kaķiem
Active substance:
- Praziquantel
- Pyrantel embonate
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel20.00/milligram(s)1.00Tablet
-
Pyrantel embonate230.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/14/0021
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0329/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 10/10/2024